- Home
- AXSM vs NCNO Comparison
AXSM vs NCNO Comparison
Compare AXSM & NCNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- NCNO
- Stock Information
- Founded
- AXSM 2012
- NCNO 2011
- Country
- AXSM United States
- NCNO United States
- Employees
- AXSM N/A
- NCNO N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- NCNO Computer Software: Prepackaged Software
- Sector
- AXSM Health Care
- NCNO Technology
- Exchange
- AXSM Nasdaq
- NCNO Nasdaq
- Market Cap
- AXSM 4.2B
- NCNO 3.9B
- IPO Year
- AXSM 2015
- NCNO 2020
- Fundamental
- Price
- AXSM $84.60
- NCNO $32.98
- Analyst Decision
- AXSM Strong Buy
- NCNO Buy
- Analyst Count
- AXSM 14
- NCNO 13
- Target Price
- AXSM $125.54
- NCNO $41.69
- AVG Volume (30 Days)
- AXSM 893.5K
- NCNO 1.3M
- Earning Date
- AXSM 02-18-2025
- NCNO 12-04-2024
- Dividend Yield
- AXSM N/A
- NCNO N/A
- EPS Growth
- AXSM N/A
- NCNO N/A
- EPS
- AXSM N/A
- NCNO N/A
- Revenue
- AXSM $338,457,000.00
- NCNO $522,980,000.00
- Revenue This Year
- AXSM $44.77
- NCNO $15.62
- Revenue Next Year
- AXSM $67.70
- NCNO $14.70
- P/E Ratio
- AXSM N/A
- NCNO N/A
- Revenue Growth
- AXSM 51.47
- NCNO 13.19
- 52 Week Low
- AXSM $64.11
- NCNO $28.09
- 52 Week High
- AXSM $105.00
- NCNO $43.20
- Technical
- Relative Strength Index (RSI)
- AXSM 43.66
- NCNO 33.78
- Support Level
- AXSM $79.19
- NCNO $32.08
- Resistance Level
- AXSM $87.53
- NCNO $35.43
- Average True Range (ATR)
- AXSM 4.37
- NCNO 0.86
- MACD
- AXSM -0.02
- NCNO -0.03
- Stochastic Oscillator
- AXSM 61.27
- NCNO 25.28
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About NCNO nCino Inc.
Ncino Inc is a provider of cloud-based software for financial institutions. Its software solution digitizes, automates, and streamlines inefficient and complex processes & workflow and utilizes data analytics & artificial intelligence that enables financial institutions to onboard new clients, make loans and manage the entire loan life cycle, open deposits, and other accounts and manage regulatory compliance. It also offers professional services, including configuration & implementation, training, and advisory services. Ncino generates the majority of its revenue from subscription services. The company caters to financial institutions, enterprise banks, regional banks, community banks, and credit unions. The vast majority of its revenue comes from the United States.